Back to mobile site

H.C. Wainwright Reiterates Buy Rating on Harrow Health (HROW)

March 19, 2025 6:42 AM EDT Send to a Friend
H.C. Wainwright analyst Yi Chen reiterated a Buy rating and $57.00 price target on Harrow Health (NASDAQ: HROW).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login